ReEngage Therapeutics, Inc. — Form D/A
ReEngage Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2025-07-01. The offering totals $8.0M, of which $365K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-07-01
- Form: D/A
- Accession: 0002022524-25-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $365K
- Remaining: $7.6M
- Investors: 6
- Date of first sale: 2025-06-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-549288
Issuer
- Name: ReEngage Therapeutics, Inc.
- CIK: 0002022524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 2450 HOLCOMBE BLVD. SUITE 1200, HOUSTON, TX, 77021
- Phone: 215-400-0133
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Thomas Kim | Director | Houston, TX |
| Thomas Kim | Executive Officer | Houston, TX |
Other filings by this issuer (2)
More